- Home
- FLNC vs VRDN Comparison
FLNC vs VRDN Comparison
Compare FLNC & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNC | VRDN |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLNC | VRDN |
|---|---|---|
| Price | $10.07 | $22.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 14 |
| Target Price | $15.71 | ★ $35.46 |
| AVG Volume (30 Days) | ★ 6.6M | 1.5M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,262,830,000.00 | $5,706,000.00 |
| Revenue This Year | $51.23 | $13.73 |
| Revenue Next Year | $21.30 | $279.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.60 | $13.18 |
| 52 Week High | $33.51 | $34.29 |
Technical Indicators
Market Signals| Indicator | FLNC | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 32.96 | 52.03 |
| Support Level | N/A | $21.62 |
| Resistance Level | $15.89 | $24.86 |
| Average True Range (ATR) | 0.53 | 0.80 |
| MACD | 0.02 | -0.30 |
| Stochastic Oscillator | 8.46 | 27.45 |
Price Performance
Historical ComparisonAbout FLNC Fluence Energy Inc.
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.